BOUSBIB ARI

CFO Ari Bousbib sold 36.6K IQV shares at $222.43 (12/18/25); holds 807.2K post-trade.

Bousbib sold 36,564 shares of IQVIA at $222.43, representing a 4.3% reduction from his pre-transaction holding of 843,727 shares. The sale occurred near the 52-week high of $231.92, with the stock currently trading at $220.69 and up 17.9% over 90 days. His recent cross-ticker track record shows a 100.00% well-timed rate on 8 prior sells (average 90-day return of -11.2%), though his same-ticker history at IQV across 5 prior sales in October 2025 has not yet produced 90-day measurable outcomes. The timing of this sale near the 52-week peak and relative strength in the stock over the recent quarter provides context for assessing the director's disposition, though no scheduled trading plan flag is noted.

Ari Bousbib sells 56,557 shares ($12.5M) at IQV in 6 transactions; maintains 807,163 shares post-sale

Ari Bousbib executed 6 separate sales totaling 56,557 shares for $12,461,119.18 on 2025-10-29, reducing his holdings by 6.5% to 807,163 shares. The blended average sale price of $220.33 sits near the 52-week high of $221.25, with the stock currently trading at $216.46 after a +6.2% 30-day gain. Across his cross-ticker track record, Bousbib's 2 prior open-market sells showed a 90-day well-timed rate of 100.00%, and his prior two sales at IQV (both on 2024-03-01) were also well-timed at the 90-day mark, establishing a consistent pattern of selling ahead of subsequent declines. This sale's proximity to the 52-week high, combined with his demonstrated timing accuracy on prior sales, represents a material divestiture that warrants investor attention.